Skip to main content

Artificial Intelligence (AI) in Neurology Operating Room Market is expected to grow at a CAGR of 49.69% by 2030

 

AI in Neurology Operating Room

BIS Research defines AI in neurology operating room as a sub-segment of the overall healthcare system wherein algorithms, software, and AI-enabled devices are used for augmenting the neurosurgical process, data management, diagnosis, and rehabilitation, among other operations which are limited to the operation theater.

The impact on AI adoption in operating rooms was low-moderate due to the fact that the global AI in neurology operating room market is in the early stage of commercialization and has been witnessing strong growth in terms of market value.

The global artificial intelligence (AI) in neurology operating room market is expected to grow at a CAGR of 49.69% during the forecast period, 2021-2030.

Many players in the global AI in operating room market have products and solutions which cater to applications such as scheduling, diagnosis, training, and instrument tracking for most of the indications. However, with time, new market entrants are expected to target niche applications and indications. Given the nature and the early phase of developments in the market, many companies have products in the pipeline, and more new players can be continuing their research and development in stealth mode.

The global AI in neurology operating room market is expected to witness tremendous growth during the forecast period 2021-2030, registering a CAGR of XX%. Leading companies in the market aim to maintain a competitive advantage with a strong global presence and advanced product portfolio.

The concept of artificial intelligence in the operating room is not a new concept. However, products have been commercialized only since 2018. Thus, most of the companies in the market have been involved in funding activities in recent years.

AI-based software used in operating rooms is rigorously trained by using numerous datasets and images that are then used for various applications, including identification of image patterns, improvement of workflow, image analysis, decision support, remote monitoring, predictive analysis, and reporting and communication.

The purpose of the study is to enable the reader to gain a holistic view of the global AI in neurology operating room market by each of the aforementioned segments. 

The report constitutes an in-depth analysis of the global AI in neurology operating room market, including a thorough analysis of the applications. The study also provides market and business-related information on various products, applications, technologies, and end users. The report considers software solutions and hardware solutions integrated with AI.

Request a Sample - https://bisresearch.com/requestsample?id=1118&type=download 


Comments

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Digital PCR Market size,Share, Leading Players, Growth, Development and Demand Forecast to 2032

  Increasing investments in R&D for d-PCR molecular diagnostics is one of the major opportunities in the global digital PCR market. Several biotechnology and life sciences companies are working collaboratively on diagnostic test development and using d-PCR as a therapeutic means for applications in several disease indications to enable efficient diagnosis, treatment selection, and treatment monitoring. The global  digital PCR market   is projected to reach $2,847.8 million by 2032 from $441.2 million in 2021, at a CAGR of 18.73% during the forecast period 2022–2032. The growth in the global digital PCR market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases globally, the rising awareness of d-PCR-based diagnostic testing, and the significant number of funding for executing research and development. Impact of COVID-19 The current global digital PCR market comprises kits and assays, system, and reagents and consuma...

Radiation Dose Management Market Likely To Increase Size, Shares, And Demand Forecast 2022-2032

  Radiation dose is the amount of radiation absorbed by a patient during a diagnostic imaging procedure. A large dose of radiation can cause tissue damage and increase the risk of developing cancer in later stages of life.The development of on-cloud dose management solutions and the growing initiatives on radiation dose management for pediatric procedures are some of the major opportunities in the global radiation dose management market. Furthermore, some of the key trends going on in the market include the increasing development of imaging modalities with technologies that lower radiation dose, partnerships and strategic business alliances dominating the market, and various collaborations among market players. The global  radiation dose management market   was valued at $212.8 million in 2021 and is anticipated to reach $586.7 million by 2032, witnessing a CAGR of 10.30% during the forecast period 2022–2032. The growth in the global radiation dose management market is ex...